✦ LIBER ✦

Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy

✍ Scribed by Linh T Nguyen,Marcus O Butler,Pei Hua Yen…

Book ID: 126381290
Publisher: Springer (Biomed Central Ltd.)
Year: 2013
Tongue: English
Weight: 65 KB
Volume: 1
Category: Article
ISSN: 2051-1426
DOI: 10.1186/2051-1426-1-S1-P25

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial of adoptive immunothe

A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer

✍ Giovanni B. Ratto; Paolo Zino; Sandro Mirabelli; Paolo Minuti; Riccardo Aquilina 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

A previous pilot study from our group suggested that: (1) adoptive immunotherapy (AI) with tumor-infiltrating lymphocytes (TIL) and recombinant interleukin-2 (rIL-2) may be applied with safety to more than 80% of the patients who had surgery for Stage 111 nonsmall cell lung carcinoma (NSCLC); and (2

Adoptive immunotherapy of advanced melan

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2

✍ Flavio Arienti; Filiberto Belli; Licia Rivoltini; Carlo Gambacorti-Passerini; Lu 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 890 KB

Adoptive immunotherapy with donor lympho

Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma

✍ Ballester, O F; Fang, T; Raptis, A; Ballester, G; Wilcox, P; Hiemenz, J; Tan, B 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 172 KB

Achievements and challenges of adoptive

Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?

✍ Svane, Inge Marie; Verdegaal, Els M. 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 249 KB

Interleukin-2 dose, blood monocyte and C

Interleukin-2 dose, blood monocyte and CD25+lymphocyte counts as predictors of clinical response to interleukin-2 therapy in patients with renal cell carcinoma

✍ Gregers G. Hermann; Poul F. Geertsen; Hans von der Maase; Jesper Zeuthen 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 583 KB